finanzen.net
27.02.2019 16:30
Bewerten
(0)

Global Dry Eye Syndrome Market Report 2019-2024: Analysis & Forecasts by Lubricant Eye Drops, Anti-Inflammatory Drugs and Autologous Serum Eye Drops

DRUCKEN

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global dry eye syndrome market was worth US$ 3.5 Billion in 2018

There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye.

Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.

Market Summary:


  • Based on the disease type, the market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.
  • Based on the drug type, the market has been segmented into lubricant eye drops, anti-inflammatory drugs and autologous serum eye drops.
  • Based on the product type, the market has been segmented into liquid drops, gel, liquid wipes, eye ointment and others.
  • Based on the distribution channels, the market has been segmented into retail pharmacies, hospital pharmacies and online pharmacies.

Key Questions Answered in This Report:

  • How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
  • What is the breakup of the global dry eye syndrome market on the basis of region?
  • What is the breakup of the global dry eye syndrome market on the basis of disease type?
  • What is the breakup of the global dry eye syndrome market on the basis of drug type?
  • What is the breakup of the global dry eye syndrome market on the basis of product type?
  • What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
  • What are the various stages in the value chain of the global dry eye syndrome market?
  • What are the key driving factors and challenges in the global dry eye syndrome market?
  • What is the structure of the global dry eye syndrome market and who are the key players?
  • What is the degree of competition in the global dry eye syndrome market?

Companies Mentioned

  • Novartis AG
  • Allergan plc.
  • Otsuka Holdings Co. Ltd.
  • Santen Pharmaceutical Co. Ltd.
  • Nicox S.A.
  • Auven Therapeutics
  • Akorn Inc.
  • Bausch + Lomb
  • Alimera Science
  • GlaxoSmithKline plc.

For more information about this report visit https://www.researchandmarkets.com/research/fvjbms/global_dry_eye?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-dry-eye-syndrome-market-report-2019-2024-analysis--forecasts-by-lubricant-eye-drops-anti-inflammatory-drugs-and-autologous-serum-eye-drops-300803173.html

SOURCE Research and Markets

Technische Marktanalyse

Wie geht's an der Börse weiter? Setzt sich der Zick-Zack-Kurs fort oder geht es demnächst kräftig nach unten? Am Montag ab 18 Uhr analysiert Achim Matzke die Situation bei Dax, Dow und Co. Jetzt kostenlos anmelden!
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht tiefer ins Wochenende -- Wall Street schließt schwächer -- Bechtle dämpft Erwartungen an Umsatzwachstum -- Broadcom, Varta, Autowerte, Rheinmetall im Fokus

CropEnergies etwas zuversichtlicher für Geschäftsjahr. Fiat Chrysler koopiert mit Engie und Enel bei Ladestationen. 1&1 Drillisch-Aktie und United Internet-Aktie von Unsicherheit geplagt. Swiss Re bringt Tochter ReAssure im Juli an Londoner Börse. Huawei: Android-Ersatz könnte "binnen Monaten" kommen. Bayer bleibt bei Glyphosat - Aber Milliarden für Alternativen.

Die 5 beliebtesten Top-Rankings

Das hat sich geändert
Diese Aktien hat George Soros im Depot
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
Das verdienen Aufsichtsratschefs in DAX-Konzernen
Deutlich unter Vorstandsgehältern
Die Länder mit den größten Goldreserven 2019
Wer lagert das meiste Gold?
Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
mehr Top Rankings

Umfrage

Sind Sie an einem Investment in die Cannabis-Branche interessiert?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Microsoft Corp.870747
Scout24 AGA12DM8
Daimler AG710000
Wirecard AG747206
Apple Inc.865985
NEL ASAA0B733
Amazon906866
TeslaA1CX3T
Beyond MeatA2N7XQ
Allianz840400
Infineon AG623100
BASFBASF11
BMW AG519000
BayerBAY001